GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

LONDON (Reuters) - GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world's leading AIDS conference next month by showcasing detailed results from its new two-drug treatment.

Source: Reuters: Health - June 20, 2018 Category: Consumer Health News Tags: healthNews Source Type: news